Results 11 to 20 of about 82,415 (224)

Alpha-Gal Sensitization Dynamics in Individuals After Tick Bites With or Without Erythema Migrans. [PDF]

open access: greenClin Exp Allergy
ABSTRACT α‐Gal syndrome (AGS) is an emerging tick‐borne disease characterised by the development of specific immunoglobulin E (sIgE) antibodies against galactose‐α‐1,3‐galactose (α‐gal), a carbohydrate found in most mammalian species, but not in humans. AGS occurs in individuals with a history of tick bites.
van Gorkom T   +8 more
europepmc   +4 more sources

Erythema Migrans: Course and Outcome in Patients Treated With Rituximab. [PDF]

open access: goldOpen Forum Infect Dis, 2019
Background Information on Lyme borreliosis (LB) in patients treated with rituximab is limited to individual case reports. Methods We reviewed data on adult patients diagnosed with typical erythema migrans (EM) at the LB outpatient clinic of the ...
Maraspin V   +4 more
europepmc   +4 more sources

Fatigue in patients with erythema migrans. [PDF]

open access: greenDiagn Microbiol Infect Dis, 2016
Wormser GP   +10 more
europepmc   +3 more sources

Ability to cause erythema migrans differs between Borrelia burgdorferi sensu lato isolates [PDF]

open access: yesParasites & Vectors, 2013
Background: Lyme borreliosis is a tick-borne disease caused by Borrelia burgdorferi sensu lato. The variety of characteristic and non-specific clinical manifestations is partially explained by its genetic diversity.
Hengeveld, P. (Paul)   +5 more
core   +5 more sources

Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice

open access: yesScandinavian Journal of Primary Health Care, 2017
Objective: Promptly treated erythema migrans (EM) has good prognosis. However, some patients report persistent symptoms. Do patients with EM have more symptoms than the general population?
Knut Eirik Eliassen   +4 more
doaj   +2 more sources

Erythema Migrans [PDF]

open access: hybridDefinitions, 2020
National Cancer Institute
openalex   +2 more sources

The Spectrum of Erythema Migrans in Early Lyme Disease: Can We Improve Its Recognition? [PDF]

open access: yesCureus, 2022
Background and objective Diagnosis of early Lyme disease (LD) often relies on clinical recognition of the skin lesion, erythema migrans (EM), a diagnostic sign of disease when laboratory testing is insensitive.
Schotthoefer AM   +3 more
europepmc   +2 more sources

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium. [PDF]

open access: yesParasit Vectors, 2022
Background A number of tick-borne pathogens circulate in the Belgian tick population in addition to the causative agent of Lyme borreliosis. However, so far, only a few patients with tick-borne diseases other than Lyme borreliosis have been reported in ...
Geebelen L   +8 more
europepmc   +2 more sources

Single-cell immunophenotyping of the skin lesion erythema migrans identifies IgM memory B cells. [PDF]

open access: yesJCI Insight, 2021
The skin lesion erythema migrans (EM) is an initial sign of the Ixodes tick–transmitted Borreliella spirochetal infection known as Lyme disease. T cells and innate immune cells have previously been shown to predominate the EM lesion and promote the ...
Jiang R   +11 more
europepmc   +2 more sources

Course and Outcome of Erythema Migrans in Pregnant Women. [PDF]

open access: yesJ Clin Med, 2020
Information on Lyme borreliosis (LB) during pregnancy is limited. In the present study, the course and outcome of erythema migrans (EM) in 304 pregnant women, diagnosed in the period 1990–2015, was assessed and compared with that in age-matched non ...
Maraspin V   +5 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy